Credit Suisse Ag Gilead Sciences, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 2,888,499 shares of GILD stock, worth $261 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,888,499

Previous 3,093,628 6.63%

Holding current value

$261 Million

Previous $251 Million 15.57%

% of portfolio

0.21%

Previous 0.25%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $14.7 Million - $17.9 Million	-205,129 Reduced 6.63%	2,888,499 $212 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $28.9 Million - $32.8 Million	-394,769 Reduced 11.32%	3,093,628 $251 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $615,550 - $671,577	8,325 Added 0.24%	3,488,397 $261 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $56,399 - $64,331	-742 Reduced 0.02%	3,480,072 $268 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $23.4 Million - $26.7 Million	302,683 Added 9.52%	3,480,814 $289 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $16.5 Million - $23.6 Million	-264,169 Reduced 7.67%	3,178,131 $273 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $5.87 Million - $6.71 Million	-98,656 Reduced 2.79%	3,442,300 $212 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $30.3 Million - $34.1 Million	-524,654 Reduced 12.9%	3,540,956 $219 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $34 Million - $42.6 Million	587,300 Added 16.88%	4,065,610 $242 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $3.68 Million - $4.17 Million	56,689 Added 1.66%	3,478,310 $253 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $13.1 Million - $14.2 Million	-194,149 Reduced 5.37%	3,421,621 $239 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $5.84 Million - $6.38 Million	92,042 Added 2.61%	3,615,770 $249 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $19.3 Million - $22 Million	-321,581 Reduced 8.36%	3,523,728 $228 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $17.3 Million - $19.7 Million	-305,747 Reduced 7.37%	3,845,309 $224 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $35.6 Million - $44.8 Million	-573,510 Reduced 12.14%	4,151,056 $262 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $90.4 Million - $105 Million	1,250,021 Added 35.98%	4,724,566 $364 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $17.8 Million - $22.8 Million	-284,767 Reduced 7.57%	3,474,545 $260 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $36.6 Million - $40.3 Million	594,677 Added 18.79%	3,759,312 $244 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $5.98 Million - $6.6 Million	95,585 Added 3.11%	3,164,635 $201 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.55 Million - $1.74 Million	-25,095 Reduced 0.81%	3,069,050 $207 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $36.2 Million - $40.5 Million	-578,682 Reduced 15.76%	3,094,145 $201 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $17.8 Million - $23.3 Million	294,732 Added 8.72%	3,672,827 $230 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $15.9 Million - $17.6 Million	223,144 Added 7.07%	3,378,095 $261 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $56.9 Million - $66.4 Million	-877,006 Reduced 21.75%	3,154,951 $223 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $11.9 Million - $14.5 Million	-163,181 Reduced 3.89%	4,031,957 $304 Million
Q4 2017 Mar 14, 2018	BUY	$71.15 - $83.52 $1.41 Million - $1.65 Million	19,805 Added 0.47%	4,195,138 $301 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $5.85 Million - $6.87 Million	82,250 Added 2.01%	4,175,333 $299 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $10.9 Million - $12.9 Million	-151,235 Reduced 3.56%	4,093,083 $332 Million
Q2 2017 Aug 14, 2017	BUY	N/A	4,244,318	4,244,318 $300 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account